Kala Pharmaceuticals, Inc. (KALA)

Exchange NASDAQ
0.3641


Currency in USD (Disclaimer)
Volume:
Day's Range:

KALA Insider Trading

Transaction Date Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price(USD) Amount(USD) SEC Filing
2022-06-16 KOVEN ANDREW I director 50,000.0 A-Award A 50,000.0 0.36 18,000.00
2022-06-16 Paull Robert Bradley director 40,000.0 A-Award A 40,000.0 0.36 14,400.00
2022-06-16 PERRY GREGORY D director 40,000.0 A-Award A 40,000.0 0.36 14,400.00
2022-06-16 Rosen Howard B director 40,000.0 A-Award A 40,000.0 0.36 14,400.00
2022-06-16 Blumenkranz Mark S. director 40,000.0 A-Award A 40,000.0 0.36 14,400.00
2022-06-16 Myers C. Daniel director 40,000.0 A-Award A 40,000.0 0.36 14,400.00
2022-05-26 RA CAPITAL MANAGEMENT, L.P. 10 percent owner 7,039,613.0 S-Sale D 1,005,686.0 0.36 365,667.43
2022-05-25 RA CAPITAL MANAGEMENT, L.P. 10 percent owner 8,045,299.0 S-Sale D 1,434,509.0 0.42 602,493.78
2022-05-24 RA CAPITAL MANAGEMENT, L.P. 10 percent owner 9,479,808.0 S-Sale D 144,805.0 0.51 73,850.55
2022-05-23 RA CAPITAL MANAGEMENT, L.P. 10 percent owner 9,624,613.0 S-Sale D 1,250,000.0 0.65 812,500.00
2022-01-04 Trachtenberg Eric officer: SEE REMARKS 153,000.0 A-Award D 153,000.0 1.37 209,610.00
2022-01-04 Trachtenberg Eric officer: SEE REMARKS 113,816.0 S-Sale D 2,850.0 1.30 3,705.00
2022-01-04 Iwicki Mark T director, officer: CHIEF EXECUTIVE OFFICER 775,000.0 A-Award D 775,000.0 1.37 1,061,750.00
2022-01-04 Iwicki Mark T director, officer: CHIEF EXECUTIVE OFFICER 259,158.0 S-Sale D 9,518.0 1.30 12,373.40
2022-01-04 Bazemore Todd officer: SEE REMARKS 238,000.0 A-Award D 238,000.0 1.37 326,060.00
2022-01-04 Bazemore Todd officer: SEE REMARKS 118,591.0 S-Sale D 3,454.0 1.30 4,490.20
2022-01-04 Brazzell Romulus K officer: SEE REMARKS 238,000.0 A-Award D 238,000.0 1.37 326,060.00
2022-01-04 Brazzell Romulus K officer: SEE REMARKS 288,345.0 S-Sale D 3,504.0 1.30 4,555.20
2022-01-04 Reumuth Mary officer: CHIEF FINANCIAL OFFICER 153,000.0 A-Award D 153,000.0 1.37 209,610.00
2022-01-04 Reumuth Mary officer: CHIEF FINANCIAL OFFICER 133,208.0 S-Sale D 2,850.0 1.30 3,705.00
2021-11-15 Kharabi Darius officer: CHIEF BUSINESS OFFICER 100,000.0 A-Award A 100,000.0 2.10 210,000.00
2021-11-15 Kharabi Darius officer: CHIEF BUSINESS OFFICER 295,657.0 A-Award A 295,657.0 0.00 0.00
2021-11-15 Blumenkranz Mark S. director 42,000.0 A-Award A 42,000.0 2.10 88,200.00
2021-11-15 Blumenkranz Mark S. director 38,965.0 A-Award A 38,965.0 0.00 0.00
2021-11-15 Blumenkranz Mark S. director 5,144,390.0 A-Award A 5,144,390.0 0.00 0.00
2021-11-15 Blumenkranz Mark S. director 157,765.0 A-Award A 157,765.0 0.00 0.00
2021-10-27 Chen Hongming officer: CHIEF SCIENTIFIC OFFICER 204,515.0 S-Sale D 21,051.0 1.82 38,312.82
2021-10-26 Trachtenberg Eric officer: SEE REMARKS 116,666.0 S-Sale D 9,449.0 1.80 17,008.20
2021-10-26 Chen Hongming officer: CHIEF SCIENTIFIC OFFICER 225,566.0 S-Sale D 9,449.0 1.80 17,008.20
2021-10-26 Reumuth Mary officer: CHIEF FINANCIAL OFFICER 136,058.0 S-Sale D 9,449.0 1.80 17,008.20
2021-10-26 Bazemore Todd officer: CHIEF OPERATING OFFICER 122,045.0 S-Sale D 12,544.0 1.80 22,579.20
2021-10-26 Iwicki Mark T director, officer: CHIEF EXECUTIVE OFFICER 268,676.0 S-Sale D 27,598.0 1.80 49,676.40
2021-10-26 Brazzell Romulus K officer: CHIEF MEDICAL OFFICER 291,849.0 S-Sale D 12,757.0 1.80 22,962.60
2021-10-15 Myers C. Daniel director 42,000.0 A-Award A 42,000.0 2.21 92,820.00
2021-06-29 Chen Hongming officer: Chief Scientific Officer 235,015.0 S-Sale D 5,548.0 5.56 30,846.88
2021-06-28 Reumuth Mary officer: Chief Financial Officer 145,507.0 S-Sale D 2,452.0 5.77 14,148.04
2021-06-28 Chen Hongming officer: Chief Scientific Officer 240,563.0 S-Sale D 2,452.0 5.77 14,148.04
2021-06-28 Bazemore Todd officer: Chief Operating Officer 134,589.0 S-Sale D 2,911.0 5.77 16,796.47
2021-06-28 Iwicki Mark T director, officer: Chief Executive Officer 296,274.0 S-Sale D 7,586.0 5.77 43,771.22
2021-06-28 Brazzell Romulus K officer: Chief Medical Officer 300,962.0 S-Sale D 3,034.0 5.77 17,506.18
2021-06-28 Trachtenberg Eric officer: See Remarks 126,115.0 S-Sale D 2,452.0 5.77 14,148.04
2021-06-17 PERRY GREGORY D director 40,000.0 A-Award A 20,000.0 0.00 0.00
2021-06-17 KOVEN ANDREW I director 53,000.0 A-Award A 25,000.0 0.00 0.00
2021-06-17 Grunberg Gregory director 40,000.0 A-Award A 20,000.0 0.00 0.00
2021-06-17 Rosen Howard B director 44,824.0 A-Award A 20,000.0 0.00 0.00
2021-06-17 Paull Robert Bradley director 40,000.0 A-Award A 20,000.0 0.00 0.00
2021-06-17 Shah Rajeev M. director, 10 percent owner 20,000.0 A-Award A 20,000.0 0.00 0.00
2021-04-01 RA CAPITAL MANAGEMENT, L.P. director, 10 percent owner 10,594,767 J-Other A 1,407,863.0 6.74 9,488,996.62
2021-04-01 RA CAPITAL MANAGEMENT, L.P. director, 10 percent owner 279,846.0 J-Other A 279,846.0 6.74 1,886,162.04
2021-03-01 Chen Hongming officer: Chief Scientific Officer 243,015.0 M-Exempt A 9,500.0 2.30 21,850.00
2021-03-01 Chen Hongming officer: Chief Scientific Officer 53,736.0 M-Exempt D 9,500.0 2.30 21,850.00
2021-02-25 Chen Hongming officer: Chief Scientific Officer 233,515.0 M-Exempt A 47,000.0 2.30 108,100.00
2021-02-25 Chen Hongming officer: Chief Scientific Officer 63,236.0 M-Exempt D 47,000.0 2.30 108,100.00
2021-01-04 Brazzell Romulus K officer: Chief Medical Officer 303,996.0 A-Award A 27,500.0 0.00 0.00
2021-01-04 Brazzell Romulus K officer: Chief Medical Officer 110,000.0 A-Award A 110,000.0 6.86 754,600.00
2021-01-04 Chen Hongming officer: Chief Scientific Officer 186,515.0 A-Award A 22,666.0 0.00 0.00
2021-01-04 Chen Hongming officer: Chief Scientific Officer 90,667.0 A-Award A 90,667.0 6.86 621,975.62
2021-01-04 Trachtenberg Eric officer: See Remarks 128,567.0 A-Award A 22,666.0 0.00 0.00
2021-01-04 Trachtenberg Eric officer: See Remarks 90,667.0 A-Award A 90,667.0 0.00 0.00
2021-01-04 Bazemore Todd officer: Chief Operating Officer 137,500.0 A-Award A 27,500.0 0.00 0.00
2021-01-04 Bazemore Todd officer: Chief Operating Officer 110,000.0 A-Award A 110,000.0 0.00 0.00
2021-01-04 Iwicki Mark T director, officer: Chief Executive Officer 303,860.0 A-Award A 76,000.0 0.00 0.00
2021-01-04 Iwicki Mark T director, officer: Chief Executive Officer 303,000.0 A-Award A 303,000.0 0.00 0.00
2021-01-04 Reumuth Mary officer: Chief Financial Officer 90,667.0 A-Award A 90,667.0 6.86 621,975.62
2021-01-04 Reumuth Mary officer: Chief Financial Officer 147,959.0 A-Award A 22,666.0 0.00 0.00
2020-10-26 Iwicki Mark T director, officer: Chief Executive Officer 227,860.0 A-Award A 178,300.0 0.00 0.00
2020-10-26 Trachtenberg Eric officer: See Remarks 105,901.0 A-Award A 61,000.0 0.00 0.00
2020-10-26 Reumuth Mary officer: Chief Financial Officer 125,293.0 A-Award A 61,000.0 0.00 0.00
2020-10-26 Chen Hongming officer: Chief Scientific Officer 163,849.0 A-Award A 61,000.0 0.00 0.00
2020-10-26 Bazemore Todd officer: Chief Operating Officer 110,000.0 A-Award A 81,000.0 0.00 0.00
2020-10-26 Brazzell Romulus K officer: Chief Medical Officer 276,496.0 A-Award A 81,000.0 0.00 0.00
2020-10-22 Bazemore Todd officer: Chief Operating Officer 42.0 P-Purchase A 40.0 0.00 0.00
2020-06-25 Rosen Howard B director 24,824.0 A-Award A 20,000.0 0.00 0.00
2020-06-25 Iwicki Mark T director, officer: Chief Executive Officer 49,560.0 A-Award A 49,560.0 0.00 0.00
2020-06-25 Bazemore Todd officer: Chief Operating Officer 29,000.0 A-Award A 19,000.0 0.00 0.00
2020-06-25 Chen Hongming officer: Chief Scientific Officer 102,849.0 A-Award A 16,000.0 0.00 0.00
2020-06-25 Trachtenberg Eric officer: See Remarks 44,901.0 A-Award A 16,000.0 0.00 0.00
2020-06-25 Shah Rajeev M. director, 10 percent owner 20,000.0 A-Award A 20,000.0 0.00 0.00
2020-06-25 KOVEN ANDREW I director 28,000.0 A-Award A 28,000.0 0.00 0.00
2020-06-25 Brazzell Romulus K officer: Chief Medical Officer 195,496.0 A-Award A 19,000.0 0.00 0.00
2020-06-25 Reumuth Mary officer: Chief Financial Officer 64,293.0 A-Award A 16,000.0 0.00 0.00
2020-06-25 Grunberg Gregory director 20,000.0 A-Award A 20,000.0 0.00 0.00
2020-06-25 PERRY GREGORY D director 20,000.0 A-Award A 20,000.0 0.00 0.00
2020-06-25 Paull Robert Bradley director 20,000.0 A-Award A 20,000.0 0.00 0.00
2020-06-19 Trachtenberg Eric officer: See Remarks 28,901.0 M-Exempt A 28,901.0 5.19 149,996.19
2020-06-19 Trachtenberg Eric officer: See Remarks 136,099.0 M-Exempt D 28,901.0 5.19 149,996.19
2020-06-09 Reumuth Mary officer: Chief Financial Officer 16,336.0 M-Exempt A 11,520.0 2.30 26,496.00
2020-06-09 Reumuth Mary officer: Chief Financial Officer 21,413.0 M-Exempt A 5,077.0 5.21 26,451.17
2020-06-09 Reumuth Mary officer: Chief Financial Officer 48,293.0 M-Exempt A 11,520.0 2.30 26,496.00
2020-06-09 Reumuth Mary officer: Chief Financial Officer 0.0 M-Exempt D 11,520.0 2.30 26,496.00
2020-06-09 Reumuth Mary officer: Chief Financial Officer 36,773.0 M-Exempt A 15,360.0 2.30 35,328.00
2020-06-05 Bazemore Todd officer: Chief Operating Officer 2.0 P-Purchase A 2.0 0.00 0.00
2020-04-09 Brazzell Romulus K officer: Chief Medical Officer 110,605.0 M-Exempt A 1,880.0 0.00 0.00
2020-04-09 Brazzell Romulus K officer: Chief Medical Officer 128,852.0 M-Exempt A 18,247.0 0.00 0.00
2020-04-09 Brazzell Romulus K officer: Chief Medical Officer 176,496.0 M-Exempt A 47,644.0 0.00 0.00
2020-04-09 Brazzell Romulus K officer: Chief Medical Officer 0.0 M-Exempt D 1,880.0 0.00 0.00
2020-04-09 Brazzell Romulus K officer: Chief Medical Officer 13,508.0 M-Exempt D 47,644.0 0.00 0.00
2020-03-30 Chen Hongming officer: Chief Scientific Officer 86,849.0 M-Exempt A 31,000.0 0.00 0.00
2020-03-30 Chen Hongming officer: Chief Scientific Officer 75,236.0 M-Exempt D 31,000.0 0.00 0.00
2020-03-16 Bazemore Todd officer: Chief Operating Officer 10,000.0 P-Purchase A 10,000.0 5.75 57,500.00

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.